Silver Book Fact

A blood thinning drug was found to reduce the risk of heart attack, stroke, and cardiovascular disease by 20% in patients with acute coronary syndrome when given in addition to aspirin.

Salim, Yusuf, D. Phil, Feng Zhao, Shamir R. Mehta, Susan Chrolavicius, Gianni Tognoni, and Keith K. Fox. Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation. N Engl J Med. 2001; 345(7): 494-502. http://content.nejm.org/cgi/content/abstract/345/7/494

Reference

Title
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
Publication
N Engl J Med
Publication Date
2001
Authors
Salim, Yusuf, D. Phil, Feng Zhao, Shamir R. Mehta, Susan Chrolavicius, Gianni Tognoni, and Keith K. Fox
Volume & Issue
Volume 345, Issue 7
Pages
494-502
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Heart Failure Disease Management (DM) Program Reduces Hospitalizations and Overall Costs  
  • About 2/3 of reduced mortality from cardiovascular disease is a result of medical interventions.  
  • There are currently 312 medicines in development for heart disease and stroke.  
  • TAVR v. SAVR in Intermediate-Risk SAS Patients
    At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical…  
  • Development of a neuroprotective drug could potentially reduce disability from stroke by 50%.